Meredith Lloyd-Evans presents at 2nd EMBRIC GA
The 2nd General Assembly of the European Marine Biological Research Infrastructure Cluster http://www.embric.eu/ was held in Faro, Portugal.
Meredith was invited to join the GA and present on the outputs and follow-on projects of the EC-funded PharmaSea project
Meredith Lloyd-Evans has given a seminar to young biotechnology, bioengineering and extremophile researchers from Chile on the Pathway for Innovation
Please contact us if you have an interest in a similar seminar for your young researchers
The PharmaSea project, of which BioBridge was a partner, has concluded http://www.pharma-sea.eu/
BioBridge managed for HealthforAnimals its 5th Global Benchmarking Survey, GBS 2015. The summary of the report is available at http://healthforanimals.org/resources-and-events/resources/publications/150-global-benchmarking-survey-2015-report.html
BioBridge selected for a second time by HealthforAnimals to manage its 5th Global Benchmarking Survey, GBS 2015
Meredith Lloyd-Evans judges the TOPRA Awards for Regulatory Excellence
BioBridge’s 25th Anniversary year 2014
Meredith Lloyd-Evans represented the PharmaSea project at Natural Product Biotechnology 2014 in Inverness
Meredith represented and presented PharmaSea at a well-attended EFIB. PharmaSea held a full day conference ‘Building Blue Biotech Capacity in Europe’ at EFIB 2014.
The PharmaSea project’s 2nd General Assembly at the Stazione Zoologica ‘Anton Dohrn’ in Naples, Italy, 7– 9 Sept 2014. Part of the meeting is open to potential end users and other parties with an interest in the discovery of new chemical entities from marine microorganisms with potential pharmaceutical, cosmeceutical or nutraceutical applications. For more information please visit www.pharma-sea.eu
BioBridge celebrates 25 years
ERA-MarineBiotech kick off meeting was held in Lillehammer Norway. This followed the preparatory action CSA MarineBiotech project http://www.marinebiotech.eu which was managed by BioBridge.